From the FCA's spreadsheet of short positions required to be disclosed to it, the following details the shorted AIM shares at the end of January 2016 (by net short position %) - and if the positions have increased (red), reduced (green) or remained unchanged (black) since last month...
Hello Share Swipers. I hope you’ve not had call to visit your doctor lately. But if you have, you’ve probably noticed a difficulty getting your appointment and a bursting surgery once you finally you got there.
Shares in EMIS Group (EMIS), a leading UK supplier of clinical software and related services to GP practices and other healthcare practitioners and a major software supplier to high street pharmacies, commenced 2013 at more than 900p but fell more than 16.5% (to 750p) on 24th January as the company reported “lower than planned revenues from the Australian defence contract, training and integrated care services. Group adjusted operating profit is expected to be marginally below analysts’ expectations, largely as a result of the accelerated staff and recruitment costs associated with the EMIS Web roll out and the slight revenue shortfalls highlighted above”. The shares have further declined since to trade at a current 650p, capitalising this AIM-listed company at £380.5 million. The following analyses whether this current, lower level represents value…








